Total Mesorectal Excision Laparoscopic Versus Transanal Approach for Rectal Cancer: A Systematic Review and Meta-analysis
Overview
Authors
Affiliations
Introduction: Total mesorectal excision (TME) performed for the first time by Held through an open approach, it has become the standard technique for the surgical treatment of rectal cancer. The aim the of this meta-analysis is to compare the outcomes provided by TaTME than LaTME.
Material And Methods: In this meta-analysis, we included all comparative studies, prospective and retrospective, which addressed in low and middle rectal cancer, a comparison between TaTME and LaTME. A search was performed through MEDLINE and Cochrane Database. 846 records were identified.
Results: Eight relevant studies have been included in this meta-analysis. The studies were from France, Russia, USA, Netherlands, Taiwan, Egypt. The eight studies including 471 patients with middle or low rectal cancer.
Conclusion: The meta-analysis confirmed safety of TaTME for low and middle rectal cancer. TaTME can lead to a high quality of rectal cancer resection specimen.
Lu F, Tan S, Zuo J, Jiang H, Wang J, Jiang Y World J Gastrointest Surg. 2025; 17(1):100364.
PMID: 39872764 PMC: 11757205. DOI: 10.4240/wjgs.v17.i1.100364.
Three-Year Analysis of the Rectal Cancer Care Trajectory after the COVID-19 Pandemic.
Braicu V, Fulger L, Nelluri A, Maganti R, Shetty U, Verdes G Diseases. 2023; 11(4).
PMID: 38131987 PMC: 10742543. DOI: 10.3390/diseases11040181.
Tejedor P, Arredondo J, Simo V, Zorrilla J, Baixauli J, Jimenez L Updates Surg. 2023; 75(8):2191-2200.
PMID: 37903996 DOI: 10.1007/s13304-023-01676-4.
Xue X, Jian C, Fang Y, Luo L, Guo Y, Ling B J Minim Access Surg. 2023; 20(1):55-61.
PMID: 37706404 PMC: 10898643. DOI: 10.4103/jmas.jmas_168_22.
Yang W, Chen W, He Z, Wu Z, Liu H, Li G Front Surg. 2023; 10:1171382.
PMID: 37576920 PMC: 10413134. DOI: 10.3389/fsurg.2023.1171382.